2023 - Research.com Microbiology in United Kingdom Leader Award
Andrew N. Phillips mainly focuses on Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort study. He interconnects Sida and Surgery in the investigation of issues within Internal medicine. His research in Immunology intersects with topics in Gastroenterology, Proportional hazards model and Antiretroviral therapy.
Andrew N. Phillips has included themes like Incidence, Disease, Hazard ratio, Seroconversion and Survival analysis in his Acquired immunodeficiency syndrome study. He combines subjects such as Zidovudine, Regimen, Pharmacotherapy, Ritonavir and Drug resistance with his study of Viral load. His Cohort study study combines topics in areas such as Epidemiology, Mortality rate, HPTN 052, Retrospective cohort study and Risk factor.
Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort are his primary areas of study. As part of his studies on Internal medicine, Andrew N. Phillips often connects relevant areas like Surgery. His Immunology research includes elements of Gastroenterology and Epidemiology.
His Acquired immunodeficiency syndrome research incorporates elements of Proportional hazards model, Seroconversion, Incidence and Pediatrics. His study in Viral load is interdisciplinary in nature, drawing from both Demography, Efavirenz, Antiretroviral therapy and Drug resistance. His Confidence interval research includes elements of Odds ratio and Poisson regression.
Andrew N. Phillips focuses on Internal medicine, Viral load, Demography, Acquired immunodeficiency syndrome and Confidence interval. Andrew N. Phillips regularly links together related areas like Oncology in his Internal medicine studies. His Viral load research is multidisciplinary, incorporating perspectives in Transmission, Prospective cohort study, Randomized controlled trial and Antiretroviral therapy.
His research in Acquired immunodeficiency syndrome focuses on subjects like Regimen, which are connected to Efavirenz, Dolutegravir and Drug resistance. He usually deals with Confidence interval and limits it to topics linked to Poisson regression and Cohort study and Ethnic group. Andrew N. Phillips combines subjects such as Ovarian cancer and Surgery with his study of Cohort.
The scientist’s investigation covers issues in Internal medicine, Demography, Viral load, Acquired immunodeficiency syndrome and Men who have sex with men. His biological study spans a wide range of topics, including Immunology and Oncology. Andrew N. Phillips has researched Viral load in several fields, including Absolute risk reduction, Health care, Randomized controlled trial, Antiretroviral therapy and Social support.
His Acquired immunodeficiency syndrome research incorporates themes from Epidemiology, Cohort study, Program evaluation, Proportional hazards model and Hazard ratio. His Cohort study research is multidisciplinary, incorporating elements of Poisson regression and Pediatrics. His research investigates the connection between Proportional hazards model and topics such as Confidence interval that intersect with issues in Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD4+ count-guided interruption of antiretroviral treatment.
Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin.
The New England Journal of Medicine (2006)
Combination antiretroviral therapy and the risk of myocardial infarction
Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)
Class of antiretroviral drugs and the risk of myocardial infarction.
Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)
Meta-analysis: Principles and procedures
Matthias Egger;George Davey Smith;Andrew N Phillips.
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Sheena McCormack;David T. Dunn;Monica Desai;David I. Dolling.
The Lancet (2016)
Changing patterns of mortality across Europe in patients infected with HIV-1.
A Mocroft;S Vella;TL Benfield;A Chiesi.
The Lancet (1998)
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft;B Ledergerber;C Katlama;O Kirk.
The Lancet (2003)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)
Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study
Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: